在人口持续老龄化时代，2型糖尿病虚弱个体中胰高血糖素样肽-1受体激动剂和钠-葡萄糖协同转运蛋白2抑制剂的安全性和疗效比较分析 - Suppr

Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing.

作者信息

Karakasis Paschalis, Patoulias Dimitrios, Ruža Ieva, Marra Alberto Maria, Gómez-Huelgas Ricardo

机构信息

Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital Hippokration, Greece.

Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, Greece.

出版信息

Eur J Intern Med. 2025 Jan;131:162-165. doi: 10.1016/j.ejim.2024.09.020. Epub 2024 Oct 2.

DOI:10.1016/j.ejim.2024.09.020

PMID:39362805

Abstract

摘要

相似文献

Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing.

Eur J Intern Med. 2025 Jan;131:162-165. doi: 10.1016/j.ejim.2024.09.020. Epub 2024 Oct 2.

Efficacy and safety of the combination or monotherapy with GLP-1 receptor agonists and SGLT-2 inhibitors in Type 2 diabetes mellitus: An update systematic review and meta-analysis.

Am J Med Sci. 2024 Dec;368(6):579-588. doi: 10.1016/j.amjms.2024.07.011. Epub 2024 Jul 6.

Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes.

Diabetes Care. 2023 Nov 1;46(11):2004-2014. doi: 10.2337/dc23-0671.

SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.

BMJ. 2024 Jun 26;385:e078483. doi: 10.1136/bmj-2023-078483.

Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

JAMA. 2018 Apr 17;319(15):1580-1591. doi: 10.1001/jama.2018.3024.

SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.

BMJ. 2021 May 11;373:n1091. doi: 10.1136/bmj.n1091.

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.

BMJ. 2021 Jan 13;372:m4573. doi: 10.1136/bmj.m4573.

Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.

BMJ. 2023 Apr 6;381:e074068. doi: 10.1136/bmj-2022-074068.

An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors.

Anatol J Cardiol. 2021 Feb;25(2):61-76. doi: 10.14744/AnatolJCardiol.2020.06630.

The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required.

Metabolites. 2025 Jan 14;15(1):49. doi: 10.3390/metabo15010049.

引用本文的文献

Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.

Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.

Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications.

Int J Mol Sci. 2025 Mar 18;26(6):2739. doi: 10.3390/ijms26062739.

Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets.

Int J Mol Sci. 2024 Dec 30;26(1):209. doi: 10.3390/ijms26010209.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing.

作者信息

Karakasis Paschalis, Patoulias Dimitrios, Ruža Ieva, Marra Alberto Maria, Gómez-Huelgas Ricardo

机构信息

Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital Hippokration, Greece.

Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, Greece.

出版信息

Eur J Intern Med. 2025 Jan;131:162-165. doi: 10.1016/j.ejim.2024.09.020. Epub 2024 Oct 2.

DOI:10.1016/j.ejim.2024.09.020

PMID:39362805

Abstract

摘要

Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing.

作者信息

机构信息

出版信息

相似文献

引用本文的文献